Status:
COMPLETED
Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the safety and IOP-lowering efficacy of various low dose travoprost formulations in patients with open-angle glaucoma or ocular hypertension.
Eligibility Criteria
Inclusion
- Patients 18 years of age or older, either sex or race with open-angle glaucoma or confirmed ocular hypertension
- Other protocol-defined inclusion criteria may apply
Exclusion
- Age related
- Other protocol-defined exclusion criteria may apply
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT00637130
Start Date
October 1 2007
Last Update
December 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon Call Center at 1-888-451-3937
Fort Worth, Texas, United States, 76134